Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥12187.1B | ¥13388.4B | −9.0% |
| Operating Income | ¥546.4B | ¥669.0B | −18.3% |
| Profit Before Tax | ¥515.3B | ¥659.5B | −21.9% |
| Net Income | ¥333.6B | ¥462.6B | −27.9% |
| ROE (Annualized) | 4.4% | 6.4% | - |
Executive Summary
The Company reported lower revenue and lower profit for the period, reflecting a further decline in profitability. Revenue was ¥1,2187.1B (down -9.0% YoY), Operating Income was ¥546.4B (down -18.3%), and consolidated Net Income was ¥333.6B (down -27.9%; of which ¥225.8B was attributable to owners of the parent, down -40.1%). Although the gross margin improved to 22.3% from the previous year, the increase in the SG&A ratio pushed the Operating Income margin down to 4.5% (5.0% in the previous year). Below Operating Income, the impact of finance costs, tax expenses, and non-controlling interests compounded, widening the decline in profit attributable to owners of the parent.
Factors Affecting Performance
【Revenue】Revenue was ¥1,2187.1B, down 9.0% YoY. The decline amounted to ¥1,201.3B and was primarily attributable to weakness in demand and volumes for chemical products, as well as weaker product spreads. Progress against the full-year forecast of ¥1,6750B was only 72.8%, slightly below the standard 75% progress benchmark.
【Profit and Loss】While the gross margin improved to 22.3% (equivalent to 21.5% in the previous year) due to a lower cost-of-sales ratio, SG&A expenses declined only marginally YoY to ¥215.25B, resulting in an increase in the SG&A ratio to 17.7%. Consequently, Operating Income was ¥546.4B (down -18.3%), and the Operating Income margin declined to 4.5% from the previous year. Finance income of ¥75.0B was offset by finance costs of ¥106.1B, resulting in net finance costs of ¥31.1B, and Profit Before Tax was ¥515.3B. After deducting income taxes of ¥181.7B (35.3% of Profit Before Tax), Net Income was ¥333.6B, while profit attributable to owners of the parent, excluding the portion attributable to non-controlling interests, was ¥225.8B (down -40.1%). Impairment losses included in operating expenses amounted to ¥104.4B (¥65.4B in the previous year), increasing earnings volatility as a temporary factor. In conclusion, the Company recorded lower revenue and lower profit.
Segment Analysis
As segment revenue and profit-and-loss data were not disclosed, no detailed analysis was conducted.
Key Financial Metrics
【Profitability】The Operating Income margin was 4.5%, down from 5.0% in the previous year, while the consolidated Net Income margin was 2.7%. Although the gross margin improved to 22.3%, the increase in the SG&A ratio to 17.7% offset this improvement, resulting in deterioration in operating leverage. Equity in earnings of affiliates was ¥139.3B, equivalent to approximately 25% of Operating Income, supporting earnings. 【Cash Flow Quality】Operating Cash Flow (OCF) was ¥1,409.7B, approximately 6.2 times profit attributable to owners of the parent of ¥225.8B, securing cash generation substantially above accounting profit. However, this included a ¥525.7B cash inflow from a decrease in trade receivables, indicating reliance on the release of working capital. 【Investment Efficiency】Annualized ROE was 4.4%, and together with an Equity Ratio of 39.7%, capital efficiency remains at a level with room for improvement. Capital expenditures of ¥924.6B represented approximately 66% of OCF, while Free Cash Flow of ¥440.0B was secured after investment. 【Financial Soundness】The Equity Ratio improved slightly to 39.7% from 39.4% in the previous year, while cash and cash equivalents increased 12.7% YoY to ¥1,922.3B. Bonds and borrowings totaled ¥758.44B, comprising current liabilities of ¥292.93B and non-current liabilities of ¥465.51B, a level sufficiently covered by current assets of ¥1,0152.8B.
Cash Flow Analysis
OCF was ¥1,409.7B, nearly unchanged from ¥1,413.6B in the same period of the previous year, demonstrating that cash generation was maintained despite the decline in accounting profit. OCF was supported by a ¥525.7B cash inflow from a decrease in trade receivables and a ¥82.9B inflow from a decrease in inventories, partly offset by a ¥126.2B decrease in trade payables. Investing Cash Flow was -¥969.7B, primarily comprising capital expenditures of ¥924.6B. Financing Cash Flow was -¥309.7B, with dividend payments of ¥281.7B representing the primary cash outflow. As a result, Free Cash Flow (OCF + Investing Cash Flow) was ¥440.0B, securing a level at which dividend payments and capital expenditures could be covered by OCF. However, the release of working capital has also contributed to the increase in OCF, and the sustainability of cash generation if trade receivables and inventory balances begin to increase again will require monitoring.
Earnings Quality
Against Operating Income of ¥546.4B, operating expenses included impairment losses of ¥104.4B (up +59.5% from ¥65.4B in the previous year), which appear to be a temporary factor and increased earnings volatility. Equity in earnings of affiliates increased 57.4% to ¥139.3B from ¥88.5B in the previous year, serving as a recurring earnings source that partially offset the decline in Operating Income. Net finance costs of ¥31.1B arose from finance income of ¥75.0B and finance costs of ¥106.1B. Profit Before Tax was ¥515.3B, and Net Income after deducting income taxes of ¥181.7B (tax rate of 35.3%) was ¥333.6B. The fact that OCF reached approximately 4.2 times consolidated Net Income and approximately 6.2 times profit attributable to owners of the parent indicates cash support exceeding accounting profit; however, attention is required because the breakdown depends on the temporary release of working capital.
Earnings Forecasts and Guidance
Progress through cumulative Q3 against the full-year forecast was 72.8% for Revenue (actual ¥1,2187.1B / forecast ¥1,6750.0B), 62.8% for Operating Income (actual ¥546.4B / ¥870.0B), and 59.6% for Net Income (actual ¥333.6B / ¥560.0B). All were below the 75% benchmark for quarterly progress, with the shortfall particularly pronounced for Operating Income. Achieving the full-year forecast will require Operating Income of approximately ¥323.6B in the remaining quarter, requiring an improvement in profitability above the cumulative Operating Income margin of 4.5%. The full-year forecast assumes YoY increases of +11.1% in Operating Income and +30.3% in Net Income, predicated on a recovery in profitability toward the second half of the fiscal year.
Shareholder Returns
The Q2 dividend was ¥75.00 per share. Total dividend payments were ¥281.7B, exceeding profit attributable to owners of the parent of ¥225.8B, resulting in a Payout Ratio calculated to be above 100%. Share repurchases were minimal at ¥0.2B, and the Total Return Ratio was approximately at the same level as the Payout Ratio. Dividend payments remained within Free Cash Flow of ¥440.0B, securing support from cash generation during the period. However, the high Payout Ratio relative to profit requires monitoring because it could constrain retained earnings capacity if the decline in profit continues.
Risk Factors
-
Profitability and Operating Leverage Deterioration Risk: The Operating Income margin declined to 4.5% from 5.0% in the previous year, with the increase in the SG&A ratio (17.7%) offsetting the improvement in the gross margin (22.3%). The Company has a structure in which fluctuations in supply and demand and product spreads are likely to have a significant impact on profit going forward.
-
Risk of Failure to Meet the Full-Year Forecast: Progress toward the full-year Operating Income forecast was only 62.8%, below the standard 75% progress benchmark. The profit level required in the remaining quarter exceeds the cumulative actual result, making a recovery in profitability in the second half of the fiscal year a prerequisite.
-
Capital Efficiency and Impairment Risk: In addition to annualized ROE of 4.4% and an Equity Ratio of 39.7%, the Company recorded impairment losses of ¥104.4B (up +59.5% YoY) during the period. Additional impairment losses on low-profitability assets or businesses could place further pressure on profit and capital efficiency.
Industry Benchmark (Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 4.5% | 8.6% (4.3%–12.7%) | −4.1pt |
| Net Income Margin | 2.7% | 6.4% (2.8%–10.3%) | −3.7pt |
The Company's profitability is below the industry median, with both its Operating Income margin and Net Income margin at lower levels.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | −9.0% | 3.3% (-2.1%–8.9%) | −12.3pt |
While many companies in the industry secured revenue growth, the Company reported lower revenue and ranked at the lower end in terms of growth.
※Source: Compiled by the Company
Key Points in the Financial Results
-
While the gross margin improved to 22.3%, the Operating Income margin declined due to the increase in the SG&A ratio. The key focus going forward will be whether cost improvements can be converted into margin expansion.
-
OCF was solid at ¥1,409.7B, and Free Cash Flow of ¥440.0B was sufficient to cover capital expenditures and dividends. However, the breakdown included temporary cash inflows from decreases in trade receivables and inventories, making continued monitoring of working capital trends important.
-
Achieving the full-year forecast will require a significant increase in the second-half Operating Income margin from the cumulative actual result. Progress will be an important point of confirmation in the next financial results.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear (bearish) | ¥2,036 |
| base (base case) | ¥2,064 |
| bull (bullish) | ¥2,086 |
| Valuation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥2,330 |
| Adjusted Forecast EPS | ¥120.0 |
| Cost of Equity r | 9.27% (10-year Government Bond 2.77% + Equity Risk Premium 6.00% + Size Premium 0.50%) |
| Persistence Coefficient of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 30.0% |
| Forecast EPS Confidence Adjustment | ×1.075 (based on the industry's historical guidance achievement rate) |
| Implied PBR / PER | 0.89x / 17.2x |
Sensitivity: ¥2,006–¥2,124 at Cost of Equity ±1%, and ¥2,055–¥2,070 at ω±0.1.
Notes:
- Net Income is substantially compressed relative to Operating Income due to tax expenses, acquisition-related costs, non-controlling interests, and other factors (Net Income ÷ Operating Income 48%). This value reflects that compression at face value; if the factors are temporary, underlying earnings power may be higher.
- Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value per Share.
- Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data and is not a forecast of the market share price or a recommendation for any specific investment action, nor does it predict or guarantee future share prices.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.
---End of Report---